Presentations from NFOG Educational Course: Polycystic Ovary Syndrome Through Life

Below you will find links to presentations or articles reviewing the topics.
(All posted with permission by the authors)

The NFOG Educational Committee hereby invites you to the NFOG Specialist Course on
Polycystic Ovary Syndrome through Life
. The course will deal with aspects of PCOS related to different ages and endocrine states of a woman´s life. Nordic and international top speakers with active research in this area will participate. The course is the second NFOG Specialist Course , planned to run each year with different topics, and aimed at specialists in Obstetrics and Gynecology, but also trainees.

Below you find the final program. The number of participants is limited to 200, due to course facilities. NFOG members (includes all members of the national societies) are welcome to register at the NFOG web-site from now on. Non-members are welcome to register from September 15 th . Reservations at different hotels in the area could be made at the same time as the registration. The course will be sponsored according to regulations by the Danish Legal Board of Self-Regulation concerning Pharmaceuticals.

Marie Bixo and Eszter Vanky
NFOG Educational Committee and local organizers

Dates: November 17th – 18th, 2010
Language: English
Venue: Park Inn Copenhagen Airport Hotel


Wednesday November 17th
13.00 – 13.05Welcome and introductionPresident of NFOG
Session 1Prenatal and early development and treatment of PCOS
13.05 – 13.30Intrauterine environment and PCOSSven M. Carlsen Professor MD (N)
13.30 – 14.00Early development & pubertal prevention of PCOS (articles):

Early Origins of Polycystic Ovary Syndrome:
Hypotheses May Change without Notice

Adipose tissue expandability and
the early origins of PCOS


Francis de Zegher Professor MD (B)
14.00 – 14.30Treatment of PCOS in adolescence (articles):

Metformin Treatment for Four Years to Reduce Total and Visceral Fat in Low Birth Weight Girls with Precocious Pubarche

Early metformin therapy to delay menarche and augment height in girls with precocious pubarche

Early Development of Visceral Fat Excess
after Spontaneous Catch-Up Growth in
Children with Low Birth Weight

Pubertal Metformin Therapy to Reduce Total, Visceral, and Hepatic Adiposity

Ethinylestradiol-Drospirenone, Flutamide-Metformin, or Both for Adolescents and Women with Hyperinsulinemic
Hyperandrogenism: Opposite Effects on Adipocytokines and Body Adiposity

Flutamide-Metformin plus Ethinylestradiol-
Drospirenone for Lipolysis and antiatherogenesis in Young Women with Ovarian Hyperandrogenism: The Key Role of Metformin at the Start and after More than
One Year of Therapy

Combined Low-Dose Pioglitazone, Flutamide, and Metformin for Women with Androgen Excess

Pioglitazone (7·5 mg/day) added to flutamide–metformin in women with androgen excess: additional increments of
visfatin and high molecular weight adiponectin

Lourdes Ibanez MD, PhD (E)
14.30 – 14.50Panel discussion and questions
14.50 – 15.20COFFEE
Session 2PCOS, pregnancy and metformin
15.20 – 15.50Metformin and ART in PCOS: A RCTSigrun Kjøtrød , MD PhD (N)
15.50 – 16.20Metformin in early pregnancy and abortionsLaure Morin-Papunen, MD PhD (SF)
16.20 – 16.50Metformin and pregnancy outcome in PCOSEszter Vanky, MD PhD (N)
16.50 – 17.20Panel discussion and questions
Thursday November 18th
Session 3PCOS in the adult woman
08.30 – 08.50PCOS, obesity in the young adultDitte Trolle MD PhD (DK)
08.50 – 09.10Metformin: When and to whom?Ditte Trolle MD PhD(DK)
09.10 – 09.30Diet and lifestyleAngelica Linden-Hirschberg MD Professor (S)
09.30 – 09.50Are there any benefits of PCOS?Angelica Linden-Hirschberg MD Professor (S)
09.50 – 10.10Panel discussion and questions
10.10 – 10.40COFFEE
Session 4Quality of life – later in life
10.40 – 11.10Quality of life in PCOSSpeaker changed.
11.10 – 11.40Cardiovascular risk factorsHarpal Randeva MD Professor (UK)
11.40 – 12.00Diabetes and PCOSSven M. Carlsen MD Professor (N)
12.00 – 12.30Premenopausal PCOS – symptoms and consequencesInger Sundström-Poromaa, MD, Professor (S)
12.30 – 13.00Panel discussion and questions
13.00 – 13.05Concluding remarksNFOG Educational Committee
Organiser:NFOG Educational CommitteeMarie Bixo and Eszter Vanky